Xeris Pharmaceuticals Inc.
XERS
|
|
| |
|
| Trading Volume | 26,298 |
|
|
3.22 - 1.47 |
| Market Cap Full | $ 386.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 6.5% | -6.4% | 22.6% | -12.6% |
| Q2 | - | 5.1% | 60.7% | -39.8% |
| Q3 | - | 12.9% | -29% | 1.3% |
| Q4 | - | -6.6% | 34.3% | -14.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.5 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 4.7 | 25 | -28.5 | -21.4 | 30.4 | -0.2 | 10.2 | 12.9 | - | - | - | - |
| 2023 | |||||||||||
| -6.8 | 11.3 | 18.1 | 38.7 | 13.3 | 2.3 | -0.4 | -13 | -18.1 | -1.6 | 1.6 | 26.3 |
| 2022 | |||||||||||
| -28 | 12.3 | 8 | -3.5 | -6.7 | -33.2 | -7.8 | 17.6 | -6.6 | 2.6 | -6.3 | -11.3 |
| 2021 | |||||||||||
| 3.3 | 7.3 | -17.3 | -15.1 | -18.5 | 30.5 | -25.1 | -9.5 | -11.2 | -24.1 | 12.4 | 40.2 |
| 2020 | |||||||||||
| -11.7 | -44.3 | -45.1 | 38.5 | 90.4 | -48.3 | 7.5 | 64.5 | 25.8 | -20.1 | -7.6 | 12.6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | 0 | -0.3 | -0.9 |
| Q2 | -0.1 | 0 | -0.4 | -0.6 |
| Q3 | -0.1 | 0 | 0 | -0.4 |
| Q4 | 0 | -0.1 | -1.6 | -0.3 |
| A | -0.35 | -0.7 | -1.6 | -2.14 |